PATENT CLAIM ANALYSIS

Application Number: 16033303
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "426000"]

Abstract:
In some aspects, the disclosure pertains to injectable particles that contain at least one pH-altering agent that is configured to be released from the injectable particles in vivo, upon embolization of an intratumoral artery of a tumor with the injectable particles. In certain instances, the pH-altering agent may be a basic agent having a pH value of 7.5, a buffering agent having a pKa value of 7.6 or more, or both. Other aspects of the disclosure pertain to preloaded containers containing such injectable particles and methods of using such injectable particles.

Claim (Index 13):
The injectable particles of  claim 11 , wherein the biostable core comprises a polymer that comprises one or more of methyl methacrylate monomer and vinyl alcohol monomer.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.73684
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14614928', '12341433', '12245365', '14828295', '13545084']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7332793632412399
- 35 USC 102 Novelty (BERT): 0.4878359392529261
- Combined Prediction Score: 0.7087350208424086
- Mean Citation Score: 196.164678
- Max Citation Score: 203.66702
- Similarity Product: 148.20553954540134

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test